1. Beta-blockers (p.244) - actions, clinical uses (angina, glaucoma, heart failure, hypertension, hyperthyroidism, migraine, MI, SVT/AF, variceal bleeding), adverse effects, selectivity (β1 vs β1/β2, nonselective, nebivolol)
2. Phosphodiesterase (PDE) inhibitors (p.245) - nonspecific, PDE-3, PDE-4, PDE-5 inhibitors, mechanism (cAMP/cGMP), uses, side effects
3. Ingested seafood toxins (p.246) - histamine (scombroid), tetrodotoxin (pufferfish), ciguatoxin, plus age-related pharmacokinetic changes
4. Specific toxicity antidotes table (p.247) - acetaminophen through warfarin, and drug reactions causing cardiovascular effects (coronary vasospasm, VANCEN dancing, red man syndrome, cardiomyopathy, QT prolongation)
5. Drug reactions - endocrine/reproductive & GI (p.248) - adrenal insufficiency, diabetes insipidus, gynecomastia, hyperprolactinemia, SIADH; cholestatic jaundice, constipation, diarrhea, hepatic necrosis, pseudomembranous colitis, etc.
6. Drug reactions - hematologic & musculoskeletal/skin (p.249) - agranulocytosis, aplastic anemia, hemolytic anemia in G6PD, DRESS syndrome; drug-induced lupus, gout, osteoporosis, Stevens-Johnson, photosensitivity, tendon rupture
7. Drug reactions - neurologic, renal, respiratory, multiorgan (p.250) - cinchonism, peripheral neuropathy, Fanconi syndrome, hemorrhagic cystitis, nephrotoxicity, pulmonary fibrosis, disulfiram-like reaction
8. Pupil effects, cytochrome P450 interactions, sulfa drug allergy (p.251) - mydriasis/miosis drugs, CYP inducers/inhibitors, sulfa cross-reactivity

1. Beta-blockers (p.244) - actions, clinical uses (angina, glaucoma, heart failure, hypertension, hyperthyroidism, migraine, MI, SVT/AF, variceal bleeding), adverse effects, selectivity (β1 vs β1/β2, nonselective, nebivolol)
2. Phosphodiesterase (PDE) inhibitors (p.245) - nonspecific, PDE-3, PDE-4, PDE-5 inhibitors, mechanism (cAMP/cGMP), uses, side effects
3. Ingested seafood toxins (p.246) - histamine (scombroid), tetrodotoxin (pufferfish), ciguatoxin, plus age-related pharmacokinetic changes
4. Specific toxicity antidotes table (p.247) - acetaminophen through warfarin, and drug reactions causing cardiovascular effects (coronary vasospasm, VANCEN dancing, red man syndrome, cardiomyopathy, QT prolongation)
5. Drug reactions - endocrine/reproductive & GI (p.248) - adrenal insufficiency, diabetes insipidus, gynecomastia, hyperprolactinemia, SIADH; cholestatic jaundice, constipation, diarrhea, hepatic necrosis, pseudomembranous colitis, etc.
6. Drug reactions - hematologic & musculoskeletal/skin (p.249) - agranulocytosis, aplastic anemia, hemolytic anemia in G6PD, DRESS syndrome; drug-induced lupus, gout, osteoporosis, Stevens-Johnson, photosensitivity, tendon rupture
7. Drug reactions - neurologic, renal, respiratory, multiorgan (p.250) - cinchonism, peripheral neuropathy, Fanconi syndrome, hemorrhagic cystitis, nephrotoxicity, pulmonary fibrosis, disulfiram-like reaction
8. Pupil effects, cytochrome P450 interactions, sulfa drug allergy (p.251) - mydriasis/miosis drugs, CYP inducers/inhibitors, sulfa cross-reactivity

What's on these pages: full topic map

1. Beta-blockers (p.244) - actions, clinical uses (angina, glaucoma, heart failure, hypertension, hyperthyroidism, migraine, MI, SVT/AF, variceal bleeding), adverse effects, selectivity (β1 vs β1/β2, nonselective, nebivolol)
2. Phosphodiesterase (PDE) inhibitors (p.245) - nonspecific, PDE-3, PDE-4, PDE-5 inhibitors, mechanism (cAMP/cGMP), uses, side effects
3. Ingested seafood toxins (p.246) - histamine (scombroid), tetrodotoxin (pufferfish), ciguatoxin, plus age-related pharmacokinetic changes
4. Specific toxicity antidotes table (p.247) - acetaminophen through warfarin, and drug reactions causing cardiovascular effects (coronary vasospasm, VANCEN dancing, red man syndrome, cardiomyopathy, QT prolongation)
5. Drug reactions - endocrine/reproductive & GI (p.248) - adrenal insufficiency, diabetes insipidus, gynecomastia, hyperprolactinemia, SIADH; cholestatic jaundice, constipation, diarrhea, hepatic necrosis, pseudomembranous colitis, etc.
6. Drug reactions - hematologic & musculoskeletal/skin (p.249) - agranulocytosis, aplastic anemia, hemolytic anemia in G6PD, DRESS syndrome; drug-induced lupus, gout, osteoporosis, Stevens-Johnson, photosensitivity, tendon rupture
7. Drug reactions - neurologic, renal, respiratory, multiorgan (p.250) - cinchonism, peripheral neuropathy, Fanconi syndrome, hemorrhagic cystitis, nephrotoxicity, pulmonary fibrosis, disulfiram-like reaction
8. Pupil effects, cytochrome P450 interactions, sulfa drug allergy (p.251) - mydriasis/miosis drugs, CYP inducers/inhibitors, sulfa cross-reactivity

PAGE 244 — BETA-BLOCKERS

The drug list

ACTIONS section

• Adrenaline normally speeds up the heart (chronotropy) and makes it squeeze harder (inotropy). Blocking β1 receptors on heart muscle reverses this: heart rate drops, force of contraction drops.
• Why does this matter? A heart that beats slower and less forcefully needs less oxygen to do its work. This is the whole logic behind using beta-blockers in angina pectoris (chest pain from a heart not getting enough oxygen) — you're not increasing oxygen supply, you're reducing oxygen demand so supply and demand match up again.

• Aqueous humor is the clear fluid inside your eye that maintains eye pressure. It's produced by a structure called the ciliary body, which has beta receptors on it. Block those receptors → less fluid made → lower eye pressure. This is why timolol eye drops treat glaucoma (a disease of dangerously high eye pressure that damages the optic nerve).

• This one needs unpacking. In heart failure, the heart is failing to pump well, so the body panics and floods itself with adrenaline/noradrenaline to try to force the heart to work harder. This sounds helpful short-term, but chronically it's toxic — it causes the heart muscle to thicken and scar in a maladaptive way called "remodeling," which makes heart failure worse over time.
• Beta-blockers block this chronic adrenaline overdrive. Counterintuitively, giving a drug that slows the heart down to a failing heart improves survival — this is one of medicine's more surprising, well-proven findings. Note: only specific beta-blockers (bisoprolol, carvedilol, metoprolol) are proven to do this — the book highlights this in red/pink as "β-blockers that curb mortality." Not all beta-blockers in this class have equal evidence for heart failure.

• Cardiac output = how much blood the heart pumps per minute (blood pressure roughly = cardiac output × resistance in blood vessels). Lowering it lowers blood pressure.
• JG cells = juxtaglomerular cells, specialized cells in the kidney that release renin, a hormone that kicks off a cascade (renin → angiotensin → aldosterone) that raises blood pressure by retaining salt/water and constricting vessels. These JG cells have β1 receptors, so blocking them means less renin released, which means less of that blood-pressure-raising cascade.
• "↓ tremor" is a bonus effect — beta receptors in skeletal muscle contribute to the fine shaking you get with anxiety or too much adrenaline; blocking them calms tremor too. This is why propranolol is sometimes used off-label for stage fright/performance anxiety.

• Excess thyroid hormone makes the body behave like it's flooded with adrenaline — fast heart rate, tremor, anxiety, sweating. Beta-blockers don't fix the thyroid problem itself, but they rapidly control these dangerous symptoms while other treatments (that actually lower thyroid hormone) take effect. Propranolol is the classic choice here.

• The AV node is the electrical "gatekeeper" between the heart's upper chambers (atria) and lower chambers (ventricles). In fast abnormal rhythms starting above the ventricles (SVT, AFib), slowing conduction through this gatekeeper prevents the ventricles from being driven too fast, which is dangerous.
• "Class II antiarrhythmic" is a classification system (Vaughan-Williams) for drugs that treat abnormal heart rhythms; Class II = beta-blockers.

• Same logic as angina: less oxygen demand protects at-risk heart muscle acutely. Long-term, beta-blockers after a heart attack reduce risk of dying, likely by preventing dangerous arrhythmias and remodeling.

• In liver cirrhosis, scarring blocks blood flow through the liver, backing pressure up into the veins around the esophagus and stomach (varices), which can rupture and cause life-threatening bleeding. Nonselective beta-blockers (nadolol, propranolol) reduce blood flow into this congested portal system by constricting the gut's blood vessels (an unopposed alpha effect once beta is blocked) and by lowering cardiac output. This lowers pressure in those fragile varices, preventing rupture — "prophylactic" means preventive, given before bleeding happens.

ADVERSE EFFECTS

• Bradycardia/AV block: the same mechanism that helps in arrhythmia can overshoot and slow the heart too much or block signals entirely.
• Masked hypoglycemia: when blood sugar drops too low, your body's warning signs (racing heart, tremor, sweating) are driven by adrenaline. Beta-blockers blunt these warning signs, so a diabetic patient on insulin might not feel their sugar crashing — dangerous.
• Asthma/COPD exacerbations: the lungs' airways are kept open partly by β2 receptor stimulation. Nonselective beta-blockers (blocking β2 too) can trigger bronchospasm (airway squeezing shut) — this is why nonselective agents are used cautiously or avoided in asthmatics.

SELECTIVITY (the most testable part)

• β1-selective antagonists (β1 > β2) — "A to M": atenolol, betaxolol, bisoprolol, esmolol, metoprolol. Mnemonic clue in the book: alphabetically these start early (A to M).
  • Why does selectivity matter? β1 receptors dominate in the heart; β2 receptors dominate in the lungs and blood vessels. A drug selective for β1 mostly affects the heart while sparing the lungs — safer in patients with asthma/COPD, though selectivity is relative, not absolute (at high doses, selectivity is lost).
• Nonselective antagonists (β1 = β2) — "N to Z": nadolol, propranolol, timolol.
  • These block both receptor types equally, affecting heart AND lungs/vessels.
• Nonselective α- and β-antagonists — carvedilol, labetalol.
  • These block alpha receptors too. Alpha receptors on blood vessels cause constriction; blocking them causes vessels to relax/dilate, adding a blood-pressure-lowering effect on top of the beta blockade. Useful in heart failure (carvedilol) and hypertensive emergencies including pregnancy (labetalol).
• Nebivolol: combines β1 selectivity with stimulation of nitric oxide (NO) synthase in blood vessels. NO is a natural vessel-relaxing molecule (same pathway Viagra works through, coincidentally, which becomes relevant on the next page). This gives nebivolol an extra vasodilating (vessel-widening) effect, lowering SVR (systemic vascular resistance — the "tightness" of the blood vessel network that blood has to push against).
• Naming trick pointed out in the book: nonselective β-antagonists tend to have "-olol" suffixes without modification, while some selective ones get an extra letter inserted mid-name (like "carvediLOL" vs how nebivolol breaks the usual mnemonic pattern) — this is just a memory device, not a deep pharmacologic rule.

PAGE 245 — PHOSPHODIESTERASE (PDE) INHIBITORS

Mechanism of action

• cAMP and cGMP are "second messenger" molecules inside cells — think of them as internal relay signals. When a receptor on the cell surface is triggered, it often works by raising the level of cAMP or cGMP inside the cell, which then triggers downstream effects (like muscle relaxation, or increased heart contraction, depending on the cell type).
• Normally, an enzyme called phosphodiesterase (PDE) breaks down (hydrolyzes) cAMP/cGMP, ending the signal.
• A "PDE inhibitor" blocks that breakdown enzyme, so cAMP/cGMP levels stay elevated longer, prolonging/amplifying whatever effect that second messenger causes in that particular tissue.
• Different PDE inhibitors target different isoforms (subtypes) of the enzyme found in different tissues, which is why one PDE inhibitor treats erectile dysfunction while another treats COPD — they're hitting the enzyme subtype dominant in that specific organ.

Nonspecific PDE inhibitor: Theophylline

• "↓ cAMP hydrolysis → ↑ cAMP → bronchial smooth muscle relaxation → bronchodilation"
• Used in COPD/asthma (rarely now — it's an older drug largely replaced by safer inhalers, hence "rarely used").
• Adverse effects: cardiotoxicity (tachycardia — fast heart rate, and arrhythmias), neurotoxicity (seizures, headache) — because it's nonspecific, it hits PDE everywhere, including the heart and brain, causing side effects beyond the lungs.

PDE-4 inhibitor: Roflumilast

• Targets the PDE-4 isoform found in neutrophils, granulocytes, and bronchial epithelium — all cells involved in airway inflammation.
• Used for severe COPD to reduce inflammatory flare-ups.
• Side effects: GI upset (nausea, diarrhea), weight loss, depression, anxiety, insomnia — because PDE-4 is also active in the brain and gut, so blocking it broadly affects mood and digestion too.

PDE-3 inhibitor: Milrinone

• "In cardiomyocytes: ↑ cAMP → ↑ Ca2+ influx → ↑ inotropy and chronotropy"
• Cardiomyocytes = heart muscle cells. More cAMP in these cells → more calcium let into the cell → calcium is what actually triggers muscle fiber contraction. More calcium = stronger, faster heartbeat (inotropy = force of contraction, chronotropy = rate).
• "In vascular smooth muscle: ↑ cAMP → ↓ MLCK inhibition → vasodilation → ↓ preload and afterload"
• Wait — this looks like it says ↑ cAMP → ↓ MLCK inhibition, but the underlying biology is: cAMP activates a pathway that inhibits MLCK (myosin light chain kinase, the enzyme that causes smooth muscle to contract). Less MLCK activity means the vessel's smooth muscle relaxes → vessel widens (vasodilation).
• Preload = how much blood fills the heart before it beats (related to how much blood is coming back through veins). Afterload = the resistance the heart has to pump against (related to how tight arteries are). Milrinone lowers both by relaxing veins (less preload) and arteries (less afterload), while also making the heart pump harder — a combination useful in acute decompensated heart failure with cardiogenic shock, where you need the heart to work better and the vessels to not be fighting it. It's used as an "inotrope" — a drug that boosts heart contraction strength, given as an IV drip in critically ill patients.
• Adverse effects: arrhythmias, hypotension (low blood pressure) — logical extensions of a drug that revs up the heart and dilates vessels; can overshoot.

PDE-5 inhibitors: Sildenafil, vardenafil, tadalafil, avanafil ("-afil" naming stem)

• "↑ cGMP → ↑ smooth muscle relaxation by enhancing NO activity → ↑ blood flow in corpus cavernosum fills the penis"
• NO (nitric oxide) is released during sexual arousal and normally raises cGMP in penile blood vessels, causing them to relax and fill with blood (an erection). PDE-5 normally breaks that cGMP down, ending the erection. Blocking PDE-5 lets cGMP linger, prolonging vessel relaxation and blood engorgement — hence treating erectile dysfunction.
• Also used for pulmonary hypertension (tadalafil only) — the same NO/cGMP relaxation pathway works in lung blood vessels too, lowering the elevated pressure in that circuit.
• Benign prostatic hyperplasia — relaxation of smooth muscle in the prostate/bladder neck eases urinary symptoms.
• Adverse effects: facial flushing, headache, dyspepsia (indigestion), hypotension in patients taking nitrates ("hot and sweaty" is the mnemonic given) — nitrates (used for angina) also raise NO/cGMP through a different route; combining the two causes a dangerous, sometimes fatal, drop in blood pressure. This is a classic must-know drug interaction.
• "heartburn," hypotension → cyanopsia (blue-tinted vision) via inhibition of PDE-6 (in retina), sildenafil only — PDE-6 is a slightly different isoform found in the retina's rod cells, involved in normal vision signaling. Sildenafil isn't perfectly selective for PDE-5 and cross-reacts a bit with PDE-6, causing that odd side effect of things looking tinted blue.

"Platelet inhibitors" — actually a mixed mechanism table for antiplatelet drugs classified alongside PDE drugs

• In platelets: ↑ cAMP → inhibition of platelet aggregation (platelets need low cAMP to clump together and form clots; raising cAMP tells them "don't clump")
• In vascular smooth muscle: ↑ cAMP → vasodilation
• Used for intermittent claudication — leg pain from poor blood flow during walking (peripheral artery disease), where both effects (better blood flow + less clotting) help.

• "A nonspecific PDE inhibitor, but categorized as a platelet inhibitor... it inhibits platelet aggregation. It also prevents adenosine reuptake by platelets → ↑ extracellular adenosine → vasodilation."
• Adenosine is a natural molecule that, when accumulated outside cells, dilates blood vessels and also further discourages platelet clumping.
• Used for stroke/TIA prevention (combined with aspirin) and for cardiac stress testing (it's used to simulate the vessel-dilating effect of exercise in patients who can't exercise, so doctors can image the heart under "stress").
• Side effects: nausea, headache, flushing, hypotension, abdominal pain — consistent with a vasodilator causing blood-pressure and GI effects.

PAGE 246 — INGESTED SEAFOOD TOXINS + AGING PHARMACOKINETICS

Ingested seafood toxins

• Source: spoiled dark-meat fish (tuna, mahi-mahi, mackerel, bonito).
• Action: "bacterial histidine decarboxylase converts histidine to histamine." Histidine is an amino acid naturally present in fish muscle. When fish isn't refrigerated properly, bacteria growing on it produce an enzyme that chemically converts histidine into histamine — the same molecule your own body releases during allergic reactions.
• "Frequently misdiagnosed as fish allergy" — because eating the fish causes flushing, hives, itching, exactly like an allergic reaction, but it's really a toxic overdose of preformed histamine already in the fish, not an immune (IgE) allergy.
• Symptoms: mimics anaphylaxis — burning sensation, facial flushing, erythema (skin redness), urticaria (hives), itching, and can progress to bronchospasm and angioedema (swelling), hypotension.
• Treatment: antihistamines, +/- albuterol and epinephrine if severe (same as treating a real allergic reaction, because the endpoint symptoms are the same even though the cause differs).

• Source: pufferfish.
• Action: "binds fast voltage-gated Na+ channels in nerve tissue, preventing depolarization." Normally, nerves fire by letting sodium rush into the cell through these channels, which is what an electrical nerve impulse actually is. Tetrodotoxin plugs these channels shut, so nerves simply cannot fire — a total paralysis toxin.
• Symptoms: nausea, diarrhea, paresthesias (abnormal tingling/numbness sensations), weakness, dizziness, loss of reflexes — all consistent with nerves failing to conduct signals properly.
• Treatment: supportive only (there's no specific antidote — you keep the patient breathing and stable, often with a ventilator, until the toxin clears).

• Source: reef fish — barracuda, snapper, moray eel.
• Action: "opens Na+ channels, causing depolarization" — the opposite problem from tetrodotoxin. Instead of blocking sodium channels shut, this toxin forces them open, so nerves fire uncontrollably/inappropriately.
• Symptoms: nausea, vomiting, diarrhea; perioral numbness (numbness around the mouth); classic "reversal of hot and cold sensations" (a hallmark clue — things that are cold feel hot and vice versa); bradycardia (slow heart rate), heart block, hypotension.
• Treatment: supportive, same reasoning as tetrodotoxin — no antidote, just manage symptoms and wait it out.

Age-related changes in pharmacokinetics

• Absorption — mostly unaffected: getting the drug into the bloodstream doesn't change much with age.
• Distribution — ↓ total body water (↓ Vd of hydrophilic drugs), ↑ total body fat (↑ Vd of lipophilic drugs): as people age, muscle and water content drop while fat proportion rises. Vd (volume of distribution) is a concept describing how "spread out" a drug becomes in the body. Water-loving (hydrophilic) drugs have less water to dissolve into, so they become more concentrated in the blood (smaller Vd, higher concentration for the same dose). Fat-loving (lipophilic) drugs, conversely, have more fat to accumulate in, so they get "trapped" there longer, extending their half-life (how long a drug stays in the body).
• Metabolism — ↓ hepatic mass and blood flow → ↓ first-pass metabolism → ↑ concentration; ↓ hepatic clearance; Phase II is relatively preserved: an aging liver is smaller and gets less blood flow, so it processes drugs less efficiently the first time they pass through it after absorption (first-pass metabolism) — meaning more of the active drug escapes into circulation, raising blood concentration. "Phase I" (oxidation reactions, often via cytochrome P450 enzymes) declines with age, but "Phase II" (conjugation reactions, like glucuronidation) is relatively spared — a nuance useful when choosing which drugs are safer in the elderly.
• Excretion — ↓ renal mass and blood flow (↓ GFR) → ↓ renal clearance: kidneys shrink and get less blood flow with age; GFR (glomerular filtration rate) — the standard measure of kidney filtering capacity — drops, so drugs cleared by the kidneys build up more and stay in the body longer.

PAGE 247 — SPECIFIC TOXICITY TREATMENTS & CARDIOVASCULAR DRUG REACTIONS

• Acetaminophen (Tylenol) → N-acetylcysteine (NAC): "replenishes glutathione." Acetaminophen overdose depletes the liver's natural antioxidant glutathione, allowing a toxic metabolite to build up and destroy liver cells. NAC restocks glutathione, mopping up the toxin before it causes liver failure.
• AChE inhibitors, organophosphates → Atropine > pralidoxime. Organophosphates (found in some pesticides and nerve agents) block acetylcholinesterase (AChE), the enzyme that normally breaks down acetylcholine — so acetylcholine builds up everywhere, overstimulating the parasympathetic nervous system (excess secretions, slow heart rate, muscle twitching). Atropine blocks acetylcholine's receptors to counter the crisis symptoms; pralidoxime actually reactivates the poisoned AChE enzyme itself, but it's less immediately life-saving than atropine, hence "Atropine > pralidoxime" in priority.
• Antimuscarinic, anticholinergic agents → Physostigmine > pralidoxime, control hyperthermia. This is opposite of the above — too little acetylcholine effect (from drugs like antihistamines, TCAs). Physostigmine boosts acetylcholine levels to counteract it. Hyperthermia (high fever) needs cooling because anticholinergic toxicity impairs sweating.
• Arsenic → Dimercaprol, succimer. These are "chelators" — molecules that grab onto heavy metal ions and drag them out of the body via urine.
• Benzodiazepines → Flumazenil: blocks the GABA receptor site where benzodiazepines act, reversing sedation (used carefully — can trigger seizures in dependent patients).
• β-blockers → Atropine, glucagon, saline: glucagon is the standout answer here — it raises heart rate/contraction through a pathway that doesn't need beta receptors, bypassing the blockade.
• Carbon monoxide → 100% O2, hyperbaric O2. CO binds hemoglobin much more tightly than oxygen does, displacing oxygen from red blood cells. Giving pure, pressurized oxygen forces more oxygen into the blood and speeds CO's removal.
• Copper → "Penny"cillamine (penicillamine), trientine ("3 copper pennies") — a mnemonic linking "penny" to copper (old pennies were copper) and to the drug name penicillamine.
• Cyanide → Hydroxycobalamin, nitrites + sodium thiosulfate. Cyanide blocks the mitochondria's ability to use oxygen (a specific enzyme, cytochrome oxidase). Hydroxycobalamin binds cyanide directly (forming vitamin B12, harmlessly excreted); thiosulfate helps convert cyanide into a less toxic, excretable form.
• Dabigatran → Idarucizumab: a monoclonal antibody designed specifically to bind and neutralize this blood thinner.
• Digoxin → Digoxin-specific antibody fragments: same logic, an antibody that mops up the drug directly.
• Direct factor Xa inhibitors (e.g., apixaban) → Andexanet alfa: a decoy protein that "soaks up" the drug instead of the body's real factor Xa.
• Heparin → Protamine sulfate: positively charged protamine binds and neutralizes negatively charged heparin.
• Iron (Fe) → Deferoxamine, deferasirox, deferiprone: iron chelators, all binding and removing excess iron.
• Lead → Dimercaprol, EDTA, succimer ("correct lead poisoning in PEDS patients"): chelators again; succimer is specifically preferred in children because it's oral and better tolerated.
• Mercury → Dimercaprol, succimer.
• Methanol, ethylene glycol (antifreeze) → Fomepizole > ethanol, dialysis. Both methanol and antifreeze are broken down by the liver into far more toxic acid byproducts. Fomepizole blocks the enzyme (alcohol dehydrogenase) responsible for that toxic conversion. Ethanol works the same way (competing for the same enzyme) but is used only if fomepizole isn't available. Dialysis removes the toxin/its breakdown products directly from blood.
• Methemoglobin → Methylene blue, vitamin C. Methemoglobin is a form of hemoglobin that can't carry oxygen properly. Methylene blue helps convert it back to normal, oxygen-carrying hemoglobin.
• Methotrexate → Leucovorin: methotrexate blocks folate metabolism (needed for making new DNA); leucovorin is an active folate form that bypasses the block, rescuing normal cells.
• Opioids → Naloxone: blocks opioid receptors directly, rapidly reversing overdose (the drug behind most opioid overdose reversal kits, like Narcan).
• Salicylates (aspirin) → NaHCO3 (alkalinizes urine). Making the urine more alkaline (basic) traps the acidic aspirin metabolite in the urine so it's excreted faster rather than being reabsorbed.
• TCAs (tricyclic antidepressants) → NaHCO3 (stabilizes cardiac cell membrane): TCA overdose disrupts heart cell sodium channels causing dangerous arrhythmias; bicarbonate helps stabilize the cell membrane's electrical behavior.
• Warfarin → Vitamin K (delayed effect), PCC (prothrombin complex concentrate, immediate effect)/FFP (fresh frozen plasma). Warfarin blocks vitamin K-dependent clotting factors. Vitamin K restores the body's own factor production, but takes time (hours to days) to work. PCC/FFP directly supply the missing clotting factors immediately, for emergencies.

Drug reactions — cardiovascular

• Coronary vasospasm — Cocaine, amphetamines, sumatriptan, ergot alkaloids ("CASE"): all of these constrict blood vessels, including the heart's own coronary arteries, which can cause a heart attack even with normal, non-blocked arteries.
• Cutaneous flushing — Vancomycin, adenosine, niacin, Ca2+ channel blockers ("VANCEN"): all cause skin blood vessel dilation via different mechanisms (histamine release, direct vasodilation, etc.), producing visible flushing.
• "VANCEN dancing" / Vancomycin infusion reaction (formerly called red man syndrome) — histamine release causing widespread flushing. "Manage with slower infusion rate; prevent with diphenhydramine, pruritic erythema" — the fix is simple: infuse the antibiotic more slowly (giving the body time to clear histamine as it's released, rather than a sudden histamine flood) and pre-treat with an antihistamine.
• Dilated cardiomyopathy — Doxorubicin, daunorubicin; prevent with dexrazoxane; trastuzumab. These chemotherapy drugs (especially the "-rubicin" class) are directly toxic to heart muscle cells over cumulative doses, weakening the heart's pumping ability permanently (dilated cardiomyopathy = an enlarged, weak heart). Dexrazoxane is a protective drug given alongside to reduce this toxicity.
• Dihydropyridine Ca2+ channel blockers (e.g., amlodipine) → peripheral edema: these vessel-relaxing drugs preferentially dilate small arteries but not veins as much, so fluid leaks out into tissues (especially ankles/legs) causing swelling.
• Torsades de pointes (a dangerous, twisting heart rhythm from prolonged QT interval) — caused by antiArrhythmics (class IA, III), antiBiotics (macrolides, fluoroquinolones), antiCyclics (TCAs), antiPsychotics (ziprasidone), antiDepressants, antiFungals (fluconazole) — memorized as "ABCDEF". All these drug classes share the ability to interfere with heart cell potassium channels, prolonging the electrical recovery time (QT interval) and predisposing to this life-threatening rhythm.

PAGE 248 — DRUG REACTIONS: ENDOCRINE/REPRODUCTIVE AND GI

Endocrine/reproductive

• Adrenocortical insufficiency — HPA suppression secondary to chronic exogenous glucocorticoid use. Your body has a feedback loop (the HPA axis: hypothalamus → pituitary → adrenal gland) that normally makes its own cortisol. If you take steroid medication (like prednisone) for a long time, your brain senses plenty of "cortisol-like" hormone already present and shuts down its own signal to the adrenal glands, which then atrophy (shrink from disuse). "Abrupt withdrawal of exogenous glucocorticoid use leads to adrenal crisis" — if you stop the steroid pill suddenly, the body has no working backup system ready, and a life-threatening cortisol deficiency crisis can occur. This is why steroids must be tapered slowly, not stopped cold.
• Diabetes insipidus — Lithium, demeclocycline. These drugs interfere with the kidney's ability to respond to ADH (antidiuretic hormone), the hormone that normally tells kidneys to conserve water. Without that response, patients urinate huge volumes of dilute urine ("insipidus" refers to tasteless/dilute urine, contrasted with diabetes mellitus's sweet urine).
• Gynecomastia — ketoconazole, cimetidine, spironolactone, GnRH analogs/antagonists, androgen receptor inhibitors, 5α-reductase inhibitors. Gynecomastia = breast tissue growth in men. These drugs all interfere with androgen (male hormone, e.g., testosterone) signaling in some way — blocking receptors, blocking synthesis, or shifting the estrogen/androgen balance — allowing relatively more estrogen effect on breast tissue.
• Hot flashes — SERMs (e.g., tamoxifen, clomiphene, raloxifene). SERMs = Selective Estrogen Receptor Modulators, drugs that block estrogen's effect in some tissues while mimicking it in others. Blocking estrogen centrally in the brain's temperature-regulation center causes hot flashes, similar to menopause.
• Hyperglycemia — Tacrolimus, protease inhibitors, niacin, HCTZ, glucocorticoids ("The people need High glucose"): all these drugs impair insulin action or secretion in various ways, raising blood sugar.
• Hyperprolactinemia — Typical antipsychotics (haloperidol), atypical antipsychotics (risperidone), metoclopramide, methyldopa, verapamil. Prolactin (the hormone that drives milk production) is normally kept in check by dopamine. These drugs block dopamine receptors, removing that brake, so prolactin rises. "Presents with hypogonadism (infertility, amenorrhea, erectile dysfunction) and galactorrhea (inappropriate milk production)" — high prolactin suppresses reproductive hormones and stimulates the breast.
• Hyperthyroidism — Amiodarone, iodine, lithium. Amiodarone is a heart rhythm drug that happens to be loaded with iodine (needed to make thyroid hormone) and can push the thyroid gland into overproduction in susceptible people.
• Hypothyroidism — Amiodarone, lithium ("I am lethargic"). Interestingly the same two drugs (amiodarone, lithium) can cause EITHER hyper- or hypothyroidism depending on the individual — a nuance worth knowing, they disrupt normal thyroid regulation unpredictably.
• SIADH — Carbamazepine, cyclophosphamide, SSRIs ("Can't Concentrate Serum Sodium"). SIADH = Syndrome of Inappropriate Antidiuretic Hormone — too much ADH causes the body to retain too much water, diluting blood sodium (hyponatremia). These drugs stimulate excess ADH release or its effect.

Gastrointestinal

• Acute cholestatic hepatitis, jaundice — Macrolides (e.g., erythromycin). Cholestasis = bile flow from the liver gets blocked, causing bilirubin buildup (jaundice = yellowing of skin/eyes).
• Constipation — Antimuscarinics (atropine), antipsychotics, opioids, non-dihydropyridine CCBs, aluminum hydroxide, loperamide, amiodarone. All these slow gut motility (movement) in different ways — blocking the nerve signals that drive peristalsis, or directly relaxing gut smooth muscle.
• Diarrhea — Acarbose, metformin, orlistat, macrolides, cholinesterase inhibitors, colchicine, lipid-lowering agents (ezetimibe, orlistat), macrolides, chemotherapy (irinotecan): mechanisms vary — some draw water into the gut, some speed motility, some irritate the gut lining.
• Focal to massive hepatic necrosis — Amanita phalloides (death cap mushroom), valproate, acetaminophen. All are directly toxic to liver cells at high enough doses/exposure.
• Pancreatitis — Diuretics (furosemide, HCTZ), glucocorticoids, alcohol, valproate, azathioprine: various direct toxic or metabolic effects on the pancreas.
• Medication-induced esophagitis — Potassium chloride, NSAIDs, bisphosphonates, ferrous sulfate, tetracyclines ("Pills Not Beneficial for food tube"). If pills get stuck against the esophagus lining (especially if taken lying down without enough water), they can directly burn/irritate the tissue.
• Pseudomembranous colitis — Ampicillin, cephalosporins, clindamycin, fluoroquinolones. These broad-spectrum antibiotics wipe out normal gut bacteria, allowing an overgrowth of Clostridioides difficile (C. diff), a resistant bacterium that then causes severe colon inflammation. "Antibiotics predispose to superinfection by resistant C difficile" is the direct mechanistic explanation.

PAGE 249 — DRUG REACTIONS: HEMATOLOGIC AND MUSCULOSKELETAL/SKIN/CONNECTIVE TISSUE

Hematologic

• Agranulocytosis — Dapsone, clozapine, carbamazepine, propylthiouracil, methimazole, ganciclovir, colchicine ("Drugs can cause pretty major granulocytes collapse"). Agranulocytosis = a dangerous drop in white blood cells (granulocytes) that fight infection, leaving the patient vulnerable to severe infections. These drugs directly suppress bone marrow production of these cells.
• Aplastic anemia — Carbamazepine, methimazole, benzene, chloramphenicol, propylthiouracil ("Can't make New blood cells"). Aplastic anemia = the bone marrow fails to make blood cells of all types (red cells, white cells, platelets), not just granulocytes — a broader marrow shutdown.
• Direct Coombs (+) hemolytic anemia — Penicillin, cephalosporins, vancomycin ("Pooh classically munches on honey Coombs"). The "Direct Coombs test" detects antibodies stuck to red blood cells. These drugs cause the immune system to mistakenly tag red cells for destruction (drug-induced immune hemolysis).
• Drug reaction with eosinophilia and systemic symptoms (DRESS) — "T cell-mediated hypersensitivity reaction, also known as drug-induced hypersensitivity syndrome (DIHS). DRESSes partially cover my skin and viscera" — a severe delayed allergic-type reaction involving skin rash plus internal organ (viscera) involvement and a rise in eosinophils (a type of white blood cell involved in allergic responses).
• Hemolysis in G6PD deficiency — Sulfonamides, dapsone, primaquine, nitrofurantoin, aspirin. G6PD is an enzyme that protects red blood cells from oxidative stress. People lacking it (a genetic condition) have red cells that rupture when exposed to oxidizing drugs like these.
• Megaloblastic anemia — Hydroxyurea, phenytoin, methotrexate ("Can Cause a mega blast with PMS" — wait, actually the mnemonic reads differently, but the concept is): these drugs interfere with DNA synthesis (folate/purine pathways), causing red blood cell precursors to grow abnormally large (megaloblastic) without dividing properly.
• Thrombocytopenia — Heparin, quinidine, ganciclovir, vancomycin, linezolid. Low platelet count — several mechanisms including immune-mediated platelet destruction (notably Heparin-Induced Thrombocytopenia, HIT, a well-known complication).
• Thrombotic complications — Combined oral contraceptives, hormone replacement therapy, SERMs, testosterone supplements ("Estrogen-mediated"). Estrogen increases production of clotting factors in the liver, raising clot risk (deep vein thrombosis, stroke) — a key counseling point for anyone on hormonal contraception/therapy.

Musculoskeletal/skin/connective tissue

• Drug-induced lupus — Hydralazine, procainamide, quinidine ("↑ blood viscosity and platelet accumulation" is actually describing a different line, ignore crossover): these drugs can trigger an autoimmune reaction mimicking lupus (joint pain, rash, fatigue) that resolves once the drug is stopped.
• Fat redistribution — Protease inhibitors, glucocorticoids ("Fat protects glutes"): these drugs cause abnormal fat redistribution (e.g., accumulation around the abdomen/back of neck, loss elsewhere).
• Gingival hyperplasia — Cyclosporine, Ca2+ channel blockers (especially phenytoin) ("Can Cause puffy gums"): these drugs stimulate overgrowth of gum tissue.
• Hyperuricemia (gout) — Pyrazinamide, thiazides, furosemide, niacin, cyclosporine ("Painful tophi and feet need care"). These drugs reduce the kidney's excretion of uric acid, letting it build up and crystallize in joints (classically the big toe), causing gout attacks. Tophi = visible uric acid crystal deposits under the skin in chronic gout.
• Malignant hyperthermia — Inhaled anesthetics (e.g., isoflurane), succinylcholine. "Individuals with ryanodine receptor mutation; antidote is dantrolene." This is a genetic condition where certain anesthesia drugs trigger uncontrolled calcium release in muscle cells (through a faulty ryanodine receptor), causing severe muscle rigidity and a life-threatening fever. Dantrolene stops this calcium release directly.
• Myopathy — Statins, fibrates, niacin, hydroxychloroquine, interferon-α, glucocorticoids. These drugs can directly damage muscle fibers, causing pain/weakness (and in severe statin cases, a dangerous condition called rhabdomyolysis).
• Osteoporosis — Glucocorticoids, depot medroxyprogesterone acetate, GnRH agonists, aromatase inhibitors, anticonvulsants, heparin, PPIs. These drugs either suppress bone-forming cells directly, lower protective hormones (like estrogen), or impair calcium absorption, weakening bone over time.
• Photosensitivity — Sulfonamides, amiodarone, tetracyclines, fluoroquinolones. These drugs make skin abnormally reactive to sunlight, causing exaggerated sunburn-like reactions.
• Steven-Johnson syndrome — Anti-epileptic drugs (especially lamotrigine), allopurinol, sulfa drugs, penicillin ("Steven Johnson has epileptic allergy to sulfa drugs and penicillin"). A severe, potentially life-threatening skin reaction causing widespread blistering and skin detachment, triggered by an abnormal immune response to these drugs.
• Tendon/cartilage discoloration/damage — Tetracyclines (teeth discoloration in children), fluoroquinolones (tendon rupture, cartilage damage). Both drug classes chelate (bind) calcium in developing bones/teeth/tendons, causing structural weakness or staining.

PAGE 250 — DRUG REACTIONS: NEUROLOGIC, RENAL/GENITOURINARY, RESPIRATORY, MULTIORGAN

Neurologic

• Cinchonism — Quinidine, quinine. "Can present with tinnitus (ringing in the ears), hearing/vision loss, psychosis, and cognitive impairment." These antimalarial/antiarrhythmic drugs, structurally related to quinine (from cinchona bark), have this characteristic set of ear/brain toxicities at higher doses.
• Parkinson-like syndrome — Antipsychotics, metoclopramide. "Cogwheel rigidity of arm" — these drugs block dopamine receptors (dopamine is essential for smooth movement control), producing symptoms that mimic Parkinson's disease (tremor, rigidity, slow movement) as a side effect.
• Peripheral neuropathy — Platinum agents (cisplatin), isoniazid, vincristine, paclitaxel, phenytoin ("Cis, it's very painful peripherally"). These drugs damage peripheral nerves (outside the brain/spinal cord), causing numbness, tingling, or pain in hands/feet — a common dose-limiting chemotherapy side effect.
• Idiopathic intracranial hypertension — Corticosteroids, danazol, vitamin A, growth hormones, tetracyclines ("Crime and debt Always grow head tension"). These drugs raise pressure inside the skull without an obvious structural cause (like a tumor), causing headaches and vision problems.
• Seizures — Isoniazid, bupropion, imipenem/cilastatin, tramadol ("With seizures, I bit my tongue"). These drugs lower the seizure threshold in the brain through various mechanisms, provoking seizures especially at high doses or in susceptible patients.
• Tardive dyskinesia — Antipsychotics, metoclopramide. A delayed (tardive = late) movement disorder from chronic dopamine blockade, causing involuntary repetitive movements (often of the face/tongue), which can be permanent even after stopping the drug.
• Visual disturbances — Topiramate (blurred vision/diplopia, haloes), hydroxychloroquine (visual field defects), digoxin (yellow-tinged vision), isoniazid (optic neuritis), ivabradine (luminous phenomena), PDE-5 inhibitors (color vision changes), ethambutol (color vision changes) ("These horrible drugs irritate Precious eyes"). Each drug affects a different part of the visual pathway (retina, optic nerve, or cortical processing), producing distinct visual symptoms — a useful diagnostic clue when a patient on one of these drugs reports vision changes.

Renal/genitourinary

• Fanconi syndrome — Cisplatin, ifosfamide, expired tetracyclines, tenofovir. Fanconi syndrome = a broad dysfunction of the kidney's proximal tubule (a part of the filtering unit), leading to wasting of glucose, amino acids, phosphate, and bicarbonate in the urine that should normally be reabsorbed. These drugs directly injure tubule cells.
• Hemorrhagic cystitis — Cyclophosphamide, ifosfamide. "Prevent by coadministering with mesna." These chemo drugs produce a toxic breakdown product (acrolein) that irritates and bleeds the bladder lining. Mesna binds and neutralizes this toxic byproduct in the urine, preventing the damage.
• Interstitial nephritis — Diuretics (furosemide, HCTZ), penicillins, NSAIDs, PPIs, rifampin, sulfa drugs ("Remember the 5 P's"). An allergic-type kidney inflammation (rather than direct toxicity) causing kidney function decline, often with fever and rash.
• Nephrotoxicity — Cisplatin, aminoglycosides, amphotericin, vancomycin. Direct toxic injury to kidney tubule cells, requiring careful dose monitoring and hydration to minimize risk.

Respiratory

• Dry cough — ACE inhibitors. ACE inhibitors block breakdown of bradykinin, a substance that can irritate airway nerves, causing a persistent dry cough in some patients (a very common reason to switch these patients to an ARB instead).
• Pulmonary fibrosis — Methotrexate, nitrofurantoin, carmustine, bleomycin, busulfan, amiodarone ("My nose cannot breathe bad air"). These drugs cause progressive scarring (fibrosis) of lung tissue with long-term use, permanently reducing lung function.

Multiorgan

• Antimuscarinic toxicity — Atropine, TCAs, H1-blockers, antipsychotics. Causes the classic "dry as a bone, blind as a bat, red as a beet, mad as a hatter, hot as a hare" toxidrome (dry mouth/skin, blurred vision, flushed skin, confusion, fever) — from blocking acetylcholine's muscarinic receptors throughout the body.
• Disulfiram-like reaction — First-generation sulfonylureas, procarbazine, certain cephalosporins, griseofulvin, metronidazole ("Sorry pals, can't go mingle"). These drugs block the enzyme that metabolizes alcohol's breakdown product (acetaldehyde dehydrogenase), so if the patient drinks alcohol, toxic acetaldehyde accumulates causing severe flushing, nausea, and vomiting — the same mechanism as the alcohol-aversion drug disulfiram itself.

PAGE 251 — PUPIL EFFECTS, CYTOCHROME P450 INTERACTIONS, SULFA ALLERGY

Drugs affecting pupil size

• Radial muscle (runs outward like spokes) — contraction is α1 receptor mediated and WIDENS the pupil (mydriasis).
• Sphincter muscle (a circular muscle) — contraction is M3 (muscarinic) receptor mediated and NARROWS the pupil (miosis).

Cytochrome P-450 interactions

Sulfa drugs (cross-reactivity/allergy)

• All of these drugs contain a sulfonamide chemical group, which some people are allergic to.
• "Patients with sulfa allergies may develop fever, urinary tract infection, Stevens-Johnson syndrome, hemolytic anemia, agranulocytosis, acute thrombocytopenia, and urticaria (hives), and photosensitivity." This ties directly back to earlier pages — sulfa allergy is a recurring theme across multiple organ systems (skin, blood, kidney), which is exactly why it shows up repeatedly across pages 249-251.